Catalyst Financial Partners’s CVS Health CVS Stock Holding History

Catalyst Financial Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$378K	Sell	5,270 -1,386	-21%	-$107K	0.04%	250
2025 Q4	$528K	Buy	6,656 +1,750	+36%	+$138K	0.06%	162
2025 Q3	$370K	Buy	4,906 +105	+2%	+$7.2K	0.04%	211
2025 Q2	$331K	Buy	4,801 +45	+0.9%	+$2.95K	0.04%	217
2025 Q1	$322K	Buy	+4,756	New	+$285K	0.06%	205
2024 Q4	–	Sell	-4,402	Closed	-$277K	–	274
2024 Q3	$277K	Buy	4,402 +345	+9%	+$20.1K	0.05%	219
2024 Q2	$240K	Sell	4,057 -1,357	-25%	-$84.9K	0.05%	219
2024 Q1	$371K	Buy	5,414 +223	+4%	+$17K	0.1%	142
2023 Q4	$410K	Sell	5,191 -638	-11%	-$45.4K	0.12%	118
2023 Q3	$407K	Buy	5,829 +962	+20%	+$68.2K	0.13%	114
2023 Q2	$336K	Buy	4,867 +943	+24%	+$67.1K	0.12%	122
2023 Q1	$292K	Sell	3,924 -606	-13%	-$50.8K	0.12%	126
2022 Q4	$422K	Buy	+4,530	New	+$437K	0.22%	69

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Catalyst Financial Partners's CVS Position: Q1 2026 in Review

Catalyst Financial Partners reduced its CVS Health (CVS) stake by 21% in Q1 2026, selling an estimated $107K and leaving 5,270 shares worth $378K. The position accounts for 0.04% of the portfolio, ranked #250.

Catalyst Financial Partners first reported a position in CVS in Q4 2022 and has held it in 13 quarters since. The position peaked at $528K in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Catalyst Financial Partners held 5,270 shares of CVS Health worth $378K as of Q1 2026.
Catalyst Financial Partners sold 1,386 CVS Health shares in Q1 2026, an estimated $107K.
CVS Health made up 0.04% of Catalyst Financial Partners's portfolio in Q1 2026, its #250 holding.
Catalyst Financial Partners first reported a position in CVS Health in Q4 2022 and has held it in 13 quarters since.
Catalyst Financial Partners's CVS Health position peaked at $528K in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Catalyst Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.